SCHEMBL29201803

SCHEMBL29201803

CCc1ccc(C(=O)C[N+](=O)[O-])cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.52
PLK1 P53350 1/20 0.47
KMT2A Q03164 6/20 0.43
MAPT P10636 6/20 0.43
MEN1 O00255 5/20 0.43
LMNA P02545 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HTT P42858 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
POLB P06746 1/20 0.43
ALOX12 P18054 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RAB9A P51151 4/20 0.43
HPGD P15428 3/20 0.43
KDM4E B2RXH2 2/20 0.43
HSD17B10 Q99714 1/20 0.43
ATM Q13315 1/20 0.42
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL104262 0.81 GSK3B (0.53) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL26687976 0.81 MAPK1 (0.57) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL18280919 0.80 POLB (0.51) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL27858771 0.79 PTPN1 (0.52) ALDH1A1MAPTLMNAHTTTDP1
SCHEMBL26966709 0.77 KMT2A (0.44) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL6782133 0.77 NPC1 (0.53) KMT2AMAPTMEN1LMNASMN1; SMN2
SCHEMBL105102 0.77 GSK3B (0.55) KMT2AMAPTMEN1LMNAPOLB
SCHEMBL2867066 0.77 GSK3B (0.67) ALDH1A1MAPTLMNATDP1GSK3B
SCHEMBL9386214 0.77 GSK3B (0.55) ALDH1A1KMT2AMAPTLMNAHTT
SCHEMBL11604083 0.76 RAB9A (0.54) ALDH1A1KMT2AMAPTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117924177-A Preparation method of pazopanib intermediate 2, 3-dimethyl-6-amino-2H-indazole and analogues thereof 南京杰运医药科技有限公司 2024-04-26 CN disclosed